Norcantharidin, a cantharidin derivative, inhibits the proliferation of giant-cell tumors of the bone by upregulating miR-30a-5p and downregulating AKT, reversed by inhibiting miR-30a-5p [62]. The gene discussed is AKT1; the disease is giant cell tumor.